A deletion in the proximal untranslated pX region of human T-cell leukemia virus type II decreases viral replication but not infectivity in vivo

Blood

Volumn 87, Issue 3, 1996, Pages 1030-1035

  Cockerell, Gary L ^c   Rovnak, Joel ^a   Green, Patrick L ^b   Chen, Irvin S Y ^d  

^a Cornell University ^*  (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; LYMPHOBLASTOID CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RABBIT; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0030043436     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1030.bloodjournal8731030     Document Type: Article

References (47)

1. Yoshida M: Expression of the HTLV-I genome and its association with a unique T-cell malignancy. Biochim Biophys Acta 907:145, 1987
2. Hinuma Y: A retrovirus associated with a human leukemia, adult T-cell leukemia. Curr Top Microbiol Immunol 115:127, 1985
3. Manns A, Blattner WA: The epidemiology of the human T-cell lymphotropic virus type I and II: Etiologic role in human disease. Transfusion 31:67, 1991
4. Gessain A, Barin F, Vernant IC, Gout O, Maurs L, Calender A, De Thé G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paresis. Lancet 2:407, 1985
5. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy: A new clinical entity Lancet 1:1031. 1986
6. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S: Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 33:392, 1993
7. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339:645, 1992
8. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY: High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 244:471, 1989
9. Kwok S, Gallo D, Hanson C, McKinney N, Poiesz B, Sninsky JJ: High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing AIDS Res Hum Retroviruses 6:559, 1990
10. Cullen B: Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev 56:375, 1992
11. Green P, Chen ISY. Regulation of human T cell leukemia virus expression. FASEB J 4.169, 1990
12. Komuro A, Watanabe T, Miyoshi I, Hayami M, Tsujimoto H, Seiki M, Yoshida M: Detection of simian retroviruses homologous to human T-cell leukemia virus type I. Virology 138:373, 1984
13. Sagata N, Yasunaga T, Tsuzuku-Kawamura J, Ohishi K, Ogawa Y, Ikawa Y: Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses. Proc Natl Acad Sci USA 82:677, 1985
14. Kiyokawa T, Seiki M, Imagawa K, Shimizu F, Yoshida M: Identification of a protein (p40x) encoded by a unique sequence pX of human T-cell leukemia virus type I. Jpn J Cancer Res 75:747, 1984
15. Seiki M, Hallori S, Yoshida M: Human adult T-cell leukemia virus: Molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA 79:6899, 1982
16. Seiki M, Inoue J, Takeda T, Yoshida M: Direct evidence that the p40x of human T-cell leukemia virus type-1 is a trans-acting transcriptional activator. EMBO J 5:561, 1986
17. Cann AJ, Rosenblatt JD, Wachsman W, Shah NP, Chen ISY: Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature 318:571, 1985
18. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN: The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229:675, 1985
19. Seiki M, Inoue J, Hidaka M, Yoshida M: Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 85:124, 1988
20. Kiyokawa TM, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M: p27XIII and p21XTII proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 82:8359, 1985
21. Inoue J, Seiki M, Yoshida M: The second pX product p27 chi-III of HTLV-I is required for gag gene expression. FEBS Lett 209:187, 1986
22. Shaw GM, Gonda MA, Flickinger BH, Hahn BH, Gallo RC, Wong-Staal F: Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX. Proc Natl Acad Sci USA 81:4544, 1984
23. Haseltine WA, Sodroski JG, Patarca R, Briggs D, Perkins D, Wong-Staal F: Structure of the 3′ terminal region of type II human T lymphotropic virus: Evidence for new coding region. Science 225:429, 1984
24. Shimotohno K, Wachsman W, Takahashi Y, Golde DW, Miwa M, Sugimara T, Chen ISY: Nucleotide sequence of the 3′ region of an infectious human T-cell leukemia virus type II genome. Proc Natl Acad Sci USA 81:6657, 1984
25. Shimotohno K, Takahashi Y, Shimizu N, Gojobori T, Chen ISY, Golde DW, Miwa M, Sugimara T: Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: A new open reading frame for the protease gene. Proc Natl Acad Sci USA 82:3101, 1985
26. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol 67:2360, 1993
27. Koralnik IJ, Gessain A, Klotman ME, Monico AL, Berneman ZN, Franchini G: Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc Natl Acad Sci USA 89:8813, 1992
28. Berneman ZW, Gartenhaus RB, Reitz MS, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, Klotman ME: Expression of alternatively spliced human T-lymphotropic virus type 1 pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci USA 89:3005, 1992
29. Caputo A, Haseltine WA: Reexammation of the coding potential of the HTLV-I pX region. Virology 188:618, 1992
30. Ciminale V, Pavlakis GN, Derse D, Cunningham CP, Felber BK: Complex splicing in the human T-cell leukemia vims (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J Virol 66:1737, 1992
31. Alexandersen S, Carpenter S, Christensen J, Storgaard T, Viuff B, Wannemuehler Y, Belousov J, Roth JA: Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 67:39, 1993
32. Aldovini A, De Rossi A, Feinberg MB, Wong-Staal F: Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: Evidence for a doubly spliced x-lor mRNA. Proc Natl Acad Sci USA 83-38, 1986
33. ex production or virus replication and transformation. J Virol 64:4914, 1990
34. rex, or envelope expression. J Virol 68:3448, 1994
35. Green PL, Ross TM, Chen ISY, Pettiford S: Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation. J Virol 69:387, 1995
36. Lainnore MD, Roberts B, Frank D, Rovnak J, Weiser MG, Cockerell GL: Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease. Int J Cancer 50:124, 1992
37. Cockerell GL, Weiser MG, Rovnak J, Wicks-Beard B, Roberts B, Post A, Chen ISY, Lairmore MD: Infectious transmission of human T cell lymphotropic virus type II in rabbits. Blood 78:1532, 1991
38. Cockerell GL, Lairmore M, De B, Rovnak J, Hartley TM, Miyoshi I: Persistent infection of rabbits with HTLV-I: Patterns of anti-viral reactivity and detection of virus by gene amplification. Int J Cancer 45:127, 1990
39. Chen ISY, McLaughlin J, Golde DW: Long terminal repeats of human T-cell leukemia virus II genome determine target cell specificity. Nature 309:276, 1984
40. Chen ISY, Slamon DJ, Rosenblatt JD, Shah NP, Quan SG, Wachsman W: The x gene is essential for HTLV replication. Science 229:54, 1985
41. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503, 1975
42. Chen ISY, Quan SQ, Golde DW: Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci USA 80:7006, 1983
43. Hartley TM, Khabbaz RF, Cannon RO, Kaplan JE, Lairmore MD: Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol 28:646, 1990
44. Degen JL, Neubauer MG, Friezner-Degen SJ, Seyfried CE, Morris DR: Regulation of protein synthesis in mitogen-activated lymphocytes: Analysis of actin-specific and total mRNA accumulation and utilization. J Biol Chem 258:12153, 1983
45. Willems L, Kerkhofs P, Dequiedt F, Portetelle D, Mammerickx M, Burny A, Kettmann R: Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci USA 91:11532, 1994
46. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC: Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 65:651, 1991
47. Baba TW, Jeong YS, Pennick D, Bronson R, Greene MF, Ruprecht RM: Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820, 1995